XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.3
Related Party Transactions - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 14, 2023
USD ($)
Nov. 22, 2023
installment
$ / shares
shares
Jul. 12, 2023
USD ($)
Jun. 22, 2023
USD ($)
May 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
seat
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Related Party Transaction [Line Items]                
Stock compensation expense           $ 25,675 $ 7,111 $ 8,038
Related party accounts payable and other current liabilities           16,584 0  
Proceeds from issuance of private placement           $ 84,555 0 0
Granted (in shares) | shares           8,776,245    
Related Party                
Related Party Transaction [Line Items]                
Related party accounts payable and other current liabilities           $ 16,600 0  
Appoint Of Board Members                
Related Party Transaction [Line Items]                
Number of board seats held by related party | seat           2    
Paragon Agreement                
Related Party Transaction [Line Items]                
Related party expenses incurred prior to asset acquisition       $ 19,000        
Related party expenses unpaid prior to asset acquisition       19,000        
Paragon Agreement | Related Party                
Related Party Transaction [Line Items]                
Research initiation fees       3,000 $ 3,000      
Reimbursable research costs       $ 16,000        
Stock compensation expense           $ 11,400    
Stock Compensation And Research And Development Expense                
Related Party Transaction [Line Items]                
Related party transaction amount           48,500    
Reimbursable Costs Under Paragon Agreement | Related Party                
Related Party Transaction [Line Items]                
Related party accounts payable and other current liabilities           16,600 0  
Milestone Payments                
Related Party Transaction [Line Items]                
Related party transaction amount           39,500    
SPY001 License Agreement | Related Party                
Related Party Transaction [Line Items]                
Nomination fee     $ 1,500          
Milestone payments     2,500          
SPY002 License Agreement | Related Party                
Related Party Transaction [Line Items]                
Nomination fee $ 1,500              
Milestone payments 2,500              
Sale Of Stock, December 2023 PIPE | Related Party                
Related Party Transaction [Line Items]                
Proceeds from issuance of private placement           10,000    
Consulting Agreement | Related Party                
Related Party Transaction [Line Items]                
Granted (in shares) | shares   477,000            
Exercise price (in dollars per share) | $ / shares   $ 10.39            
Number of monthly installments | installment   48            
Stock-based compensation expense           $ 100 $ 0 $ 0
Consulting Agreement | Related Party | Share-Based Payment Arrangement, Tranche One                
Related Party Transaction [Line Items]                
Vesting percentage   25.00%            
Awards granted, vesting period   1 year            
Paragon Therapeutics Inc | Ownership Interest | Maximum | Related Party                
Related Party Transaction [Line Items]                
Percentage of ownership by noncontrolling owner           5.00%    
Paragon Therapeutics Inc | SPY001 License Agreement | Maximum | Related Party                
Related Party Transaction [Line Items]                
Contingent obligation based on milestones     $ 22,000          
Paragon Therapeutics Inc | SPY002 License Agreement | Maximum | Related Party                
Related Party Transaction [Line Items]                
Contingent obligation based on milestones $ 22,000              
Fairmount Funds Management LLC | Ownership Interest | Minimum | Related Party                
Related Party Transaction [Line Items]                
Percentage of ownership by noncontrolling owner           5.00%    
Percentage of ownership held in third party           5.00%